Your browser doesn't support javascript.
loading
Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study.
Otabil, Kenneth Bentum; Basáñez, María-Gloria; Ankrah, Blessing; Bart-Plange, Emmanuel John; Babae, Theophilus Nti; Kudzordzi, Prince-Charles; Darko, Vera Achiaa; Raji, Abdul Sakibu; Datsa, Lydia; Boakye, Andrews Agyapong; Yeboah, Michael Tawiah; Fodjo, Joseph Nelson Siewe; Schallig, Henk D F H; Colebunders, Robert.
Afiliación
  • Otabil KB; Centre for Research in Applied Biology, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana. Kenneth.otabil@uenr.edu.gh.
  • Basáñez MG; Department of Biological Science, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana. Kenneth.otabil@uenr.edu.gh.
  • Ankrah B; Global Health Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Kenneth.otabil@uenr.edu.gh.
  • Bart-Plange EJ; Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis (MRC GIDA), London Centre for Neglected Tropical Disease Research, School of Public Health, Imperial College London, London, UK.
  • Babae TN; Centre for Research in Applied Biology, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana.
  • Kudzordzi PC; Centre for Research in Applied Biology, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana.
  • Darko VA; Centre for Research in Applied Biology, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana.
  • Raji AS; Centre for Research in Applied Biology, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana.
  • Datsa L; Centre for Research in Applied Biology, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana.
  • Boakye AA; STU Clinic, Sunyani Technical University, Sunyani, Bono Region, Ghana.
  • Yeboah MT; Department of Biological Science, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana.
  • Fodjo JNS; Deo Gratias Medical Laboratories, Sunyani, Bono Region, Ghana.
  • Schallig HDFH; Kintampo Health Research Centre, Kintampo, Bono Region, Ghana.
  • Colebunders R; Ghana Health Service, Regional Neglected Tropical Diseases (RNTD) Office, Regional Health Directorate, Sunyani, Bono Region, Ghana.
BMC Infect Dis ; 23(1): 805, 2023 Nov 16.
Article en En | MEDLINE | ID: mdl-37974087
ABSTRACT

BACKGROUND:

The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and therapeutic coverage. In addition to coverage, high levels of treatment adherence are paramount. We investigated factors associated with ivermectin intake in an area of Ghana with persistent Onchocerca volvulus infection.

METHODS:

In August 2021, a cross-sectional mixed-methods study was conducted in 13 onchocerciasis-endemic communities in the Bono Region of Ghana. Individuals aged ≥ 10 years were invited to participate in a questionnaire survey. A total of 48 focus group discussions and in-depth interviews with 10 community drug distributors and 13 community leaders were conducted.

RESULTS:

A total of 510 people participated in the study [median age 32, interquartile range 30 (20‒50) years]; 274 (53.7%) were females. Of the total, 320 (62.7%) declared that they adhered to each treatment round and 190 (37.3%) admitted they had not taken ivermectin during at least one MDA round, since becoming eligible for treatment. Of 483 participants with complete information, 139 (28.8%) did not take ivermectin during the last round (March 2021), and 24 (5.0%) had never taken ivermectin (systematic non-adherers). Reasons for not taking ivermectin included previous experience/fear of side-effects, being absent during MDA, pregnancy, the desire to drink alcohol, and drug distribution challenges. Being male, having good knowledge and perception of the disease, and not having secondary or higher level of formal education were significantly associated with higher odds of ivermectin intake.

CONCLUSIONS:

A relatively high level of non-adherence to ivermectin treatment was documented. There is a need for targeted educational and behavioural change campaigns to reverse these trends and ensure a steady course toward meeting onchocerciasis elimination targets in Ghana.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncocercosis / Ivermectina Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Ghana

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncocercosis / Ivermectina Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Ghana